• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDSII VIO 27IN 5-0 S/A RB-3; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDSII VIO 27IN 5-0 S/A RB-3; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Model Number D9745
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/21/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint #: (b)(4).Additional information has been requested and the following was received.If further details are received at a later date a supplemental medwatch will be sent.Was there any change in the patient¿s post-operative care due to the prolonged procedure? no further information is available.Were there any unexpected outcomes or complications as a result of the prolonged surgery time? no further information is available.Please clarify if the 2 devices returned are just samples? or did these 2 devices present this issue (pull off suture needle)? please clarify.No further information is available.Device return follow-up.We regularly contact with sales rep about the device returning.No further information will be provided.A manufacturing record evaluation was performed for the finished device batch and no non-conformances were identified.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
It was reported a patient underwent a robotic pancreaticoduodenectomy on (b)(6) 2022 and suture was used.After suturing inside of the body, when the surgeon tried to take out the product from the trocar, it was noticed that the needle had been detached from the suture and only the suture was taken out.The detached needle was found near the seal of the trocar.The operation time was extended more than 30 minutes.It was not a control release needle.Further details are not provided.There were no adverse consequences to the patient.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Date sent to the fda: 1/5/2023.H6 component code: g07002 no device problem found.H3 investigational summary: the product was returned to ethicon for evaluation.Visual inspection and functional test evaluation were conducted on the returned device.Visual analysis of the returned sample determined that one packet that pertains to product code d9745 was returned for analysis.Upon initial inspection, of the sample, no external damages were observed on the packet.In order to evaluate the conditions of the returned sample, the packet was opened, and no defects were detected.The swage and attachment area were noted to be as expected.The suture was dispensed without problems and examined along the strand to detect any issues related no defects observed during the evaluation.A functional test was performed using an instron equipment, and the pull force result was above the minimum requirements.The event described could not be confirmed as the device performed without any defect noted.It should be noted that as part of our quality process, each batch is randomly inspected and functionally tested during manufacturing to ensure the device meets the required specifications prior to shipment.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDSII VIO 27IN 5-0 S/A RB-3
Common Device Name
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
avenida de las torres 7125,
col salvacar
ciudad juarez 32604
MX   32604
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key15990894
Report Number2210968-2022-10321
Device Sequence Number20385611
Product Code NEW
UDI-Device Identifier10705031034549
UDI-Public10705031034549
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
N18331
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2026
Device Model NumberD9745
Device Catalogue NumberD9745
Device Lot NumberRCMJRQ
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/13/2022
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/22/2022
Supplement Date Received by Manufacturer12/16/2022
Initial Report FDA Received Date12/15/2022
Supplement Report FDA Received Date01/05/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/15/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-